The economic burden of melanoma in the UK: A stage-specific cost analysis underscoring the importance of prevention and early diagnosis

Mistry, Khaylen, Bagdatoglou, George, Daniels, Susanna, Lorigan, Paul, Levell, Nick J., Proby, Charlotte and Venables, Zoe C. (2026) The economic burden of melanoma in the UK: A stage-specific cost analysis underscoring the importance of prevention and early diagnosis. British Journal of Dermatology, 194 (1). pp. 167-168. ISSN 0007-0963

Full text not available from this repository. (Request a copy)

Abstract

This article reports the average cumulative costs of melanoma by stage in 2023 and models costs over the next 10 years. These data highlight the marked difference in cost between stage I and IV melanoma, with stage IV melanoma costing 22.5 times more than stage I melanoma in 2023. This cost difference is predicted to further increase over the next decade and emphasizes the need to deliver a comprehensive melanoma public health strategy that includes primary prevention and early detection.

Item Type:	Article
Additional Information:	Data availability: The data underlying this article will be shared on reasonable request to the corresponding author. Funding information: This study was supported by Melanoma Focus (registered charity number 1124716).
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Science > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Centres > Public Health
Related URLs:	http://www.scopus.com/inward/record.url?... https://academic.oup.com/bjd/advance-art...
Depositing User:	LivePure Connector
Date Deposited:	14 Nov 2025 17:30
Last Modified:	27 Jan 2026 09:30
URI:	https://ueaeprints.uea.ac.uk/id/eprint/101006
DOI:	10.1093/bjd/ljaf393

Actions (login required)

View Item